Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay

Abstract

MMA can be used to evaluate the ability of RBC autoantibodies to mediate overt hemolysis. It can be especially useful to determine the role played by cold and warm auto-antibodies in mixed auto-immune hemolytic disease, helping to define the best treatment option.